Cramer Highlights Buying Opportunity in AI Stocks Amid Market Cooling

On Friday, stocks fell as investors reacted to the May jobs report, which showed non-farm payrolls increased by 172,000, exceeding expectations, while unemployment remained steady at 4.3%. This economic data led to a rise in Treasury yields, raising concerns about a possible interest rate hike later this year, which could negatively impact stock prices.

The Nasdaq dropped 1.7% and the S&P 500 fell nearly 1%, marking a potential end to its nine-week winning streak. Jim Cramer highlighted this market pullback as a 'cooling off period' that could be advantageous for investors looking to buy undervalued chip stocks, specifically mentioning Intel as a good buying opportunity after its 6% drop on Friday.

The decline in chipmakers was exacerbated by Broadcom's disappointing guidance, which caused a 20% drop in its stock over the week. Meanwhile, investors are shifting towards defensive sectors like health care, with stocks such as Johnson & Johnson, Eli Lilly, and Cardinal Health seeing gains.

CrowdStrike's stock continued to decline, falling 3.4%, as CEO George Kurtz indicated that expectations for earnings boosts from Anthropic's AI model are premature. Cramer sees this as a potential entry point for new investors in CrowdStrike, anticipating a strong upcoming quarter.

Additionally, Apple is set to unveil a significant upgrade to Siri at its Worldwide Developers Conference, which is expected to positively impact its stock. The upcoming SpaceX IPO is also a point of caution, as Cramer warns that investors might be selling existing holdings to accommodate new IPOs, including those of Anthropic and OpenAI later this year

Aktien in diesem Artikel

Unternehmen Preis Änderung Änderung % KI
Intel INTC.US 116.96 +9.92 +9.27% Halten
CrowdStrike CRWD.US 691.53 +43.79 +6.76% Halten
Broadcom AVGO.US 385.57 +13.47 +3.62% Halten
Cardinal Health CAH.US 221.16 +4.86 +2.25% Kaufen
Eli Lilly LLY.US 1,160.95 +24.58 +2.16% Kaufen
Apple AAPL.US 295.63 +4.05 +1.39% Halten
Johnson & Johnson JNJ.US 238.33 -0.16 -0.07% Kaufen

Mehr economy Nachrichten